froidir 100 mg tabletti
orion corporation - clozapinum - tabletti - 100 mg - klotsapiini
clozapine accord 25 mg tabletti
accord healthcare b.v. - clozapine - tabletti - 25 mg - klotsapiini
clozapine accord 100 mg tabletti
accord healthcare b.v. - clozapine - tabletti - 100 mg - klotsapiini
clozapine accord 200 mg tabletti
accord healthcare b.v. - clozapine - tabletti - 200 mg - klotsapiini
froidir 25 mg tabletti
orion corporation - clozapine - tabletti - 25 mg - klotsapiini
froidir 100 mg tabletti
orion corporation - clozapine - tabletti - 100 mg - klotsapiini
zerbaxa
merck sharp & dohme b.v. - ceftolozane sulfaatti -, natrium-tatsobaktaami - bakteeri-infektiot - systeemiset bakteerilääkkeet, - zerbaxa is indicated for the treatment of the following infections in adults:complicated intra abdominal infections;acute pyelonephritis;complicated urinary tract infections;hospital-acquired pneumonia (hap), including ventilator associated pneumonia (vap). on otettava huomioon viralliset ohjeet antibioottien tarkoituksenmukaisesta käytöstä.
ubit 100 mg tabletti, kalvopäällysteinen
otsuka pharmaceutical europe ltd. - c13-ureum - tabletti, kalvopäällysteinen - 100 mg - muut diagnostiset aineet
senshio
shionogi b.v. - ospemifeeniä - postmenopause - sukupuolihormonit ja genitaalijärjestelmään vaikuttavat aineet, - senshio is indicated for the treatment of moderate to severe symptomatic vulvar and vaginal atrophy (vva) in post-menopausal women.
zeposia
bristol-myers squibb pharma eeig - ozanimod hydrochloride - multiple sclerosis, relapsing-remitting; colitis, ulcerative - immunosuppressantit - multiple sclerosiszeposia is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis (rrms) with active disease as defined by clinical or imaging features. ulcerative colitiszeposia is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis (uc) who have had an inadequate response, lost response, or were intolerant to either conventional therapy or a biologic agent.